Previous 10 | Next 10 |
AFM24 combination with atezolizumab (AFM24-102): Follow-up of the Phase 1/2a combination study confirmed four responses in the non-small cell cancer (NSCLC) EGFR -wildtype cohort: one complete response (CR), three partial responses (PR), and seven stable disease patients in the 15 heavily p...
MANNHEIM, Germany, March 21, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced today that it will release full ye...
2024-03-14 10:00:17 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Waters, Moderna most shorted ...
2024-03-11 09:02:02 ET Affimed N.V. (AFMD) announced stock split at a ratio of 1-for-10 on 2024-03-11 ... Full story available on KlickAnalytics.com
2024-03-08 09:43:32 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Astra Space (NASDAQ: ASTR ) stock is in the news Friday after the U.S. space travel company revealed plans to go private . Astra Space is being taken private by a new parent...
2024-03-08 09:01:28 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips AerSale (NASDAQ: ASLE ) stock is down on Friday after releasing its earnings report for the fourth quarter of 2023. The bad news for ASLE stockholders starts with the aftermarke...
2024-03-08 08:37:06 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Affimed (NASDAQ: AFMD ) stock is on the move Friday as investors prepare for the clinical-stage biopharmaceutical company’s shares to undergo a reverse split later today ...
2024-03-06 06:47:44 ET More on Affimed Affimed CEO Adi Hoess to step down, Andreas Harstrick appointed interim CEO Affimed sells AbCheck unit for $6M Seeking Alpha’s Quant Rating on Affimed Historical earnings data for Affimed Financial informa...
MANNHEIM, Germany, March 06, 2024 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD) (“Affimed” or the “Company”), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, announced that the Company, with prior appro...
Data update from AFM24-102 Phase 1/2a combination study includes 15 heavily pre-treated patients from the EGFR- wildtype (wt) non-small cell lung cancer (NSCLC) expansion cohort Follow-up shows three of the initially reported responses have now been confirmed (1 CR, 2 PR) and one still aw...
News, Short Squeeze, Breakout and More Instantly...
2024-06-17 17:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SunPower Corporation (SPWR) is expected to report $-0.29 for Q1 2024 Siemens Healthineers AG ADR (SMMNY) is expected to report for Q2 2024 Specificity Inc Com (SPTY) is expected to report for Q1 2024 Tokyo Gas Co. Ltd. ADR (TKGSY) is expected to report for Q4 2024 Gol Linhas Aerea...